NOTCH1 and urinary bladder carcinoma: The above results indicate that METTL14 may target Notch1 to inhibit progression of bladder cancer and spread of bladder TICs, which reveals that the METTL14‐m6A‐Notch1 axis has the potential to serve as an underlying target for the treatment of bladder cancer.